AstraZeneca’s Dapagliflozin gets marketing authorisation for chronic kidney disease in India
AstraZeneca India has received marketing authorisation for their anti-diabetic drug dapagliflozin, in India for the treatment of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Anil Kukreja
AstraZeneca’s Dapagliflozin (Forxiga) gets marketing authorisation in India
The drug will be used to treat patients with heart failure
AstraZeneca Pharma India (AstraZeneca India), received the…